-
10 years of CSCO: the golden years of new cancer drugs in China
Time of Update: 2021-10-23
At that time, multi-targeted TKI was still "sweet and sweet"-the world's first small-molecule anti-angiogenesis targeted drug approved for the treatment of advanced gastric cancer emerged, but today it seems that apatinib has expanded after its launch in 2014 The pace of the indication was not smooth, and it was not until January this year that the second indication (second-line advanced liver cancer) was finally approved .
-
"Nature" sub-published Phase 2 clinical data of Junshengtai original innovative drug
Time of Update: 2021-10-23
Text|Pharmaceutical Mission HillsRecently, Nature Communications, a subsidiary of Nature, published online the clinical Phase 2 trial data of Junshengtai's original innovative drug HTD1801 for non-alcoholic steatohepatitis with type 2 diabetes (NASH + T2DM) .
-
The Regulations on the Supervision and Administration of Children's Cosmetics are released and will come into force on January 1, 2022
Time of Update: 2021-10-22
Recently, the State Food and Drug Administration issued an announcement and issued the "Regulations on the Supervision and Administration of Children's Cosmetics" (hereinafter referred to as the "Reg
-
Andorra Pharmaceuticals first researched oral third-generation breast cancer new drug AND019 approved for clinical use in the U.S.
Time of Update: 2021-10-22
This is another innovative drug approved for global clinical development after the company's leading domestic new anemia drug AND017 was approved by the US FDA for Phase II clinical trials earlier this year .
-
The evaluation threshold is raised! CDE releases important guiding principles for crystal form research, APIs, preparations...
Time of Update: 2021-10-22
Recently, CDE's official website has successively released a number of technical guidelines, among which the "Technical Guidelines for the Study of Crystal Forms of Chemical Generic Drugs (Draft for
-
Affected all pharmaceutical companies, ushered in a major overhaul after 14 years!
Time of Update: 2021-10-22
On September 27, 2021, the State Food and Drug Administration announced the 72nd National Day Operation-Public Solicitation of "Drug Recall Management Measures (Draft for Comment)" (Deadline for comm
-
The results of the untrustworthy evaluation of the price recruitment credit evaluation are released, involving 5 companies including North China Pharmaceutical
Time of Update: 2021-10-22
The Shandong provincial-level centralized pharmaceutical procurement agency will assess the enterprise as "serious" untrustworthy in accordance with the provisions of the price recruitment credit evaluation system .
Henan provincial-level pharmaceutical centralized procurement agency will assess the enterprise as "serious" untrustworthy in accordance with the provisions of the price recruitment credit evaluation system .
-
Shaanxi Provincial Food and Drug Administration Solicits Opinions on Implementation Rules for Credit Restoration of Drug Supervision and Administration
Time of Update: 2021-10-22
Article 7 [Application Conditions] If a party has been included in the drug safety "blacklist" for one year and meets the following circumstances, he can apply for credit restoration in accordance with the provisions of these Measures: (1) Has consciously performed the obligations specified in the administrative penalty decision; (2) Has taken the initiative to eliminate the harmful consequences and adverse effects; (3) Has not received severe administrative penalties from the drug regulatory authority .
-
Amgen PSCK9 monoclonal antibody approved for new indications for pediatric patients over 10 years old
Time of Update: 2021-10-22
The results showed that after 12 weeks of continuous treatment with IBI306 in Chinese heterozygous familial hypercholesterolemia patients treated with statin and/or ezetimibe, compared with placebo, low-density lipoprotein cholesterol (LDL-C ) The level has been significantly improved .
-
Oseltamivir Phosphate Capsules, a wholly-owned subsidiary of Renfu Pharmaceutical, obtained US FDA approval
Time of Update: 2021-10-22
Epic Pharma submitted an ANDA application for oseltamivir phosphate capsules in 2020, with a cumulative R&D investment of approximately US$1.
IQVIA according to statistics, in 2020 the total sales of the drug in the US market of about $ 140 million, mainly manufacturers, including Amneal, Lupin and so on .
-
Domestic biopharmaceuticals welcome the golden age, which will drive the growth of demand for fluid process equipment
Time of Update: 2021-10-22
Domestic biopharmaceuticals usher in the golden age, which will drive the growth of demand for fluid process equipment (picture source: Pharmaceutical Network) The biopharmaceutical market is developing rapidly.
Conclusion In general, with the rapid development of the biopharmaceutical industry, the demand for related equipment is expected to increase .
-
Teyi Pharmaceutical: Pyrazinamide tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-10-22
Pyrazinamide tablets are anti-tuberculosis drugs that can be combined with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol) for the treatment of tuberculosis .
-
The multi-billion-dollar chronic cough market is vacant with P2X3 antagonists coming
Time of Update: 2021-10-22
According to the announcement, TCR1672 is a second-generation highly selective P2X3 receptor antagonist, currently mainly used in the treatment of refractory chronic cough (RCC) adult patients in the respiratory field and endometriosis in the pain field and other complex internal organs Pain patients .
-
During the "Golden Nine and Silver Ten" job-hopping season, the flow of talents in the pharmaceutical industry continues...
Time of Update: 2021-10-22
Due to his job change, he applied to resign from the position of general manager of the company and still served as secretary of the company’s party committee and chairman of the board after resignation .
-
The biomedical industry has entered the era of "hard technology", where are the future development opportunities?
Time of Update: 2021-10-22
In addition, in terms of cluster development, benefiting from a variety of favorable factors such as national policies, markets, and capital, the industry believes that the development of national biomedical parks (bases, medicine valleys, science and technology cities, innovation demonstration zones) is in the ascendant .
-
The market structure of tens of billions of inhalation preparations is gradually ushering in new changes
Time of Update: 2021-10-22
In recent years, with the increase in the incidence of respiratory diseases in China and the support of relevant national policies, the domestic inhalation market is also continuing to expand .
-
Pfizer 20-valent Pneumococcal Conjugate Vaccine Phase 3 Clinical Results Positive
Time of Update: 2021-10-22
On September 29, 2021, Pfizer announced that a phase 3 clinical trial of the 20-valent pneumococcal conjugate vaccine Prevnar 20 has achieved positive top-line results .
Reference materials:[1] Positive Top-Line Results Of Pfizer'S Phase 3 Study Exploring Coadministration Of Prevnar 20™ With Seasonal Flu Vaccine In Older Adults Released.
-
Suitable for a wide range of tumor types, innovative peptide-conjugated drugs to enhance the effect of immunotherapy
Time of Update: 2021-10-22
▲The mechanism of using low pH insert peptides to deliver anti-cancer drugs to tumor cells (picture source: Cybrexa official website)The researchers used a mouse model of colorectal cancer to further evaluate the effect of CBX-12 on the efficacy of PD-1 and CTLA4 immune checkpoint inhibitors .
-
National Food and Drug Administration: Conversion of Aloe Pearl Capsules from Prescription Drugs to Over-the-Counter Drugs
Time of Update: 2021-10-22
Variety of over-the-counter drug instructions templateAloe Pearl Capsule InstructionsPlease read the instructions carefully and use according to the instructions or purchase and use under the guidance of a pharmacist[Drug Name]Generic name: aloe pearl capsulesChinese Pinyin:[Ingredients][Properties][Functions and Indications] Clearing heat and leading to stagnation, promoting qi and defecation .
-
Two injections of Sansheng Guojian were approved for clinical use
Time of Update: 2021-10-22
On October 8, Sansheng Guojian issued an announcement stating that the company has recently received 4 "Drug Clinical Trial Approval Notices" approved and issued by the State Food and Drug Administrat